Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study

TW Clark, 2009, Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine., N Engl J Med, 361, 2424, 10.1056/NEJMoa0907650

E Plennevaux, 2010, Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials., Lancet, 375, 41, 10.1016/S0140-6736(09)62026-2

Z Vajo, 2010, Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009–10 influenza season: a multicentre, randomised controlled trial 291., Lancet, 375, 49, 10.1016/S0140-6736(09)62039-0

L Garcia-Garcia, 2009, Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City., BMJ, 339, b3928, 10.1136/bmj.b3928

H Kelly, 2009, Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination., Euro Surveill, 14, 10.2807/ese.14.31.19288-en

P Gargiullo, 2009, Effectiveness of 2008–09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May–June 2009., MMWR Morb Mortal Wkly Rep, 58, 1241

DM Skowronski, 2010, Association between the 2008–09 seasonal influenza vaccine and pandemic H1N1 illness during Spring–Summer 2009: four observational studies from Canada 294., PLoS Med, 7, e1000258, 10.1371/journal.pmed.1000258

M Valenciano, 2008, First steps in the design of a system to monitor vaccine effectiveness during seasonal and pandemic influenza in EU/EEA Member States 2., Euro Surveill, 13, 19015, 10.2807/ese.13.43.19015-en

D Pitigoi, 2009, [Efficiency of seasonal influenza vaccine in persons older than 65 in Romania. Pilot case-control study I-MOVE, 2008–2009] 301., Bacteriol Virusol Parazitol Epidemiol, 54, 109

C Savulescu, 2010, Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network-Pilot case-control studies using different control groups, 2008–2009 season, Spain., Vaccine, 28, 2903, 10.1016/j.vaccine.2010.01.054

E Kissling, 2009, “I-MOVE” towards monitoring seasonal and pandemic influenza vaccine effectiveness: lessons learnt from a pilot multi-centric case-control study in Europe, 2008–9., Euro Surveill, 14, 19388, 10.2807/ese.14.44.19388-en

2010, European Influenza Surveillance Network (EISN).

Commission Decision 2009/363/EC of 30 April 2009 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council, OJ L 110, 1.5.208, p. 58.

JA Sterne, 2009, Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls., BMJ, 338, b2393, 10.1136/bmj.b2393

TT Hien, 2010, Early pandemic influenza (2009 H1N1) in Ho Chi Minh City, Vietnam: a clinical virological and epidemiological analysis., PLoS Med, 7, e1000277, 10.1371/journal.pmed.1000277

L Rodrigues, 1990, Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls., Int J Epidemiol, 19, 205, 10.1093/ije/19.1.205

EA Belongia, 2009, Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004–2005 season to the 2006–2007 season., J Infect Dis, 199, 159, 10.1086/595861

DM Fleming, 2010, Estimating Influenza vaccine effectiveness using routinely collected laboratory data., J Epidemiol Community Health, 64, 1062, 10.1136/jech.2009.093450

H Kelly, 2009, Estimation of influenza vaccine effectiveness from routine surveillance data., PLoS One, 4, e5079, 10.1371/journal.pone.0005079

DM Skowronski, 2009, Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006–2007., J Infect Dis, 199, 168, 10.1086/595862

M Blettner, 1999, Traditional reviews, meta-analyses and pooled analyses in epidemiology., Int J Epidemiol, 28, 1, 10.1093/ije/28.1.1

ML Jackson, 2008, Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study., Lancet, 372, 398, 10.1016/S0140-6736(08)61160-5

O Wichmann, 2010, Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010., Euro Surveill, 15, 19561, 10.2807/ese.15.18.19561-en

J Puig-Barbera, 2010, Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellon, Spain. A test-negative, hospital based, case-control study., Vaccine, 28, 7460, 10.1016/j.vaccine.2010.09.042

CR Simpson, 2010, Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine., Health Technol Assess, 14, 313, 10.3310/hta14340-05

DM Skowronski, 2007, Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada., Vaccine, 25, 2842, 10.1016/j.vaccine.2006.10.002